SEC Filing Update: #COAG Hemab Therapeutics Holdings, Inc. : $48.11

Sector: Healthcare | YTD: 🔼+ 41.33% The SEC disclosed Today (05-AUG-2026) that Sofinnova Crossover II SLP has Newly bought 2,511,212 #COAG shares Ownership: 5.4% * Estimated Investment Value: $118.00M https://www.thinksabio.com/reports/isr/COAG